A Mobile App for Medication Adherence in Persons With Hypertension: a Pilot Study

A development and pilot test of an app targeting persons with hypertension. Content in the app was based on persons with hypertensions experiences and a literature review. The participants experience of using the app as well as testing a instrument for medication adherence.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Behavior Cardiovascular Diseases Health Behavior Medication Adherence Patient Acceptance of Health Care Patient Compliance Treatment Adherence and Compliance Vascular Diseases

Age range

40 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Halmstad University

Halmstad, Sweden

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

40-70 years of age,
have hypertension (i.e., ICD 10 codes I10-I15 in the person's medical history) for ≥1 year
have been prescribed medications to treat said hypertension
speak and understand Swedish
have a smartphone

Exclusion criteria

having received medication with unit-dose packages (Apodos)
previous stroke
previous myocardial infarction
psychological disorder or cognitive impairment (i.e. ICD 10 codes F01-F99)
pregnancy-induced hypertension´
insulin treatment
kidney disease, defined as glomerulus filtration rate (GFR) <60 ml/min.

Treatment and study plan

Adaptive digital intervention

Other

Participants received reminder for medication intake on daily basis. Also, short message regarding hypertension, medication and lifestyle changes

Primary outcomes

Medication adherence

Time frame: two weeks

Medication adherence measured by the participants self-reported intake of daily medication in the app.

The usage is described in frequencies and response time.
Adherence hypertension medication

Time frame: two weeks

Medication score through the Maastricht Utrecht Adherence in Hypertension (MUAH-16) questionnaire.

The questionnaire consists of four subscales: two of them measures positive and two others measures negative aspects of attitudes to medication adherence and health problem. Min value for each subscale are 4 and maximum 28. Higher value indicate better outcome

Sponsors and collaborators

Lead sponsor

Halmstad University

Other

Collaborators

Vinnova

Registry information

Official study title

Adaptive Digital Interventions Through Mobile App for Medication Adherence Improvement in Persons With Hypertension: a Pilot Study for Usability

Important dates

Study start: 2020
Primary completion: 2021
Study completion: 2021
First posted: Jan 29, 2024
Registry last updated: Mar 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed